University Hospitals Seidman Cancer Center Provides Innovative Treatments for Patients with Mixed Gliomas
If you or a loved one has been diagnosed with a glioblastoma (GBM) brain tumor, we understand your fear of the unknown, and we have the expertise to treat the tumor. UH Seidman Cancer Center’s physicians working closely with specialists from University Hospitals Neurological Institute's Brain Tumor and Neuro-Oncology Center are leading experts at diagnosing and treating glioblastomas, tailoring brain cancer treatment to each patient’s age, health conditions and individual needs. Our entire multidisciplinary cancer care team evaluates and reviews every case so diagnosis and treatment decisions are based on the knowledge of a team of distinguished experts. Together, we work through every step of cancer care, always with a cure mind.
Innovations in Treating Glioblastoma
With groundbreaking clinical trials, UH Seidman Cancer Center’s physicians have established many innovations in treating glioblastoma and other brain cancers. UH Seidman Cancer Center is part of the National Cancer Institute-designated Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine, which is one of an elite group of 41 comprehensive cancer hospitals nationwide.
This means we have access to advance treatments and therapies sooner than most other hospitals. With groundbreaking clinical trials, UH Seidman Cancer Center’s physicians have established many innovations in special treatment of glioblastoma.
Further, we have access to the latest technology for brain tumors, including:
Compassionate, Highly Trained Team of Experts
UH Seidman Cancer Center puts the patient at the center of a compassionate, highly accomplished team of brain cancer experts, including:
- Genetic counselors
- Medical geneticists
- Medical oncologists
- Nurse navigators
- Nurse practitioners
- Radiation oncologists
- Social workers
- Surgical oncologists
Weekly Tumor Board Review
At UH Seidman Cancer Center, each patient’s case is presented at weekly tumor board meetings. Our multidisciplinary team, including radiologists, pathologists and surgical oncologists, performs a disease-specific tumor board review. This review process ensures that all realistic treatment options are considered.
Mixed Gliomas Cancer Clinical Trials
UH Seidman Cancer Center has many available clinical trials for patients with mixed gliomas, including:
- Gene Therapy for GBM (reference Case 6307)
- Immunotherapy for GBM (NRGBN0002)
- Evaluating using radiation with or without chemo for patients with Anaplastic Glioma. Learn more.
- Studying an antibody and a device that uses electricity to treat Gliobastoma Multiforme (GBM) that has come back. Learn more.